ARCT-021

· Arcturus Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARCT-021, covering 2021-08-18 to 2025-05-15. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults [Phase 2]